FALLBACK

Serial Number 85565683
606

Registration Progress

Application Filed
Mar 9, 2012
Under Examination
Sep 25, 2012
Approved for Publication
Jul 31, 2012
Published for Opposition
Jul 31, 2012
Registered

Trademark Image

FALLBACK

Basic Information

Serial Number
85565683
Filing Date
March 9, 2012
Published for Opposition
July 31, 2012
Abandonment Date
October 28, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 28, 2013
Classes
005

Rights Holder

Lupin Limited

99
Address
Bandra (W) B/4 Laxmi Towers
Bandra Kurla Complex
Mumbai 400051
IN

Ownership History

Lupin Limited

Original Applicant
99
Mumbai IN

Lupin Limited

Owner at Publication
99
Mumbai IN

Legal Representation

Attorney
Robert L. Powley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description
Oct 28, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 28, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 9, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 8, 2013 EX1G S SOU EXTENSION 1 GRANTED
Jan 28, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 28, 2013 EXT1 S SOU EXTENSION 1 FILED
Sep 25, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 31, 2012 PUBO A PUBLISHED FOR OPPOSITION
Jul 31, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2012 DOCK D ASSIGNED TO EXAMINER
Jun 18, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2012 MPMK O NOTICE OF PSEUDO MARK MAILED
Mar 16, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2012 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation; transdermal patches used for contraceptive purposes
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
FALL BACK

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...